Form D · Biotechnology
Biopep Solutions Inc.
Richmond, A1 · CIK 0001658895
Offering snapshot reported Mar 21, 2016 · SEC filing
- Reported sold
- $15K Offering amount: $15K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 21, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2016 | Initial | $15,000 | No comparison | 1 | SEC filing |
| Nov 30, 2015 | Initial | $7,607 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-259635
U.S. dollar amounts are based on the Bank of Canada noon rate of exchange reported on January 21, 2016, which was Cdn$1.4243=US$1.00.
Source: Form D, filed Mar 21, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aspha J. Dada | Director, Executive |
| Yalcin Ilsever | Director, Executive |
| Ahmed Merzouk | Director, Executive |
| Suzanne Stratton | Executive |
| Gary Yalloway | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
220 13071 Vanier Place
Richmond, A1, V6V 2J1
Richmond, A1, V6V 2J1